Neem formulation 55% effective in preventing Covid, says Nisarga Biotech
May 20, 2021
Nisarga Biotech Pvt Ltd, which offers 40 natural therapeutic products for chronic diseases, recently launched Nisarga Neem Capsules that has proven to be an effective preventive remedy for Covid-19 after its recently concluded clinical trials in April 2021.
BusinessLine caught up with the Satara, Maharashtra headquartered company’s founder and CEO Girish Soman, to find out more. Excerpts:
What led to the creation of Nisarga’s neem capsules as a prophylactic for Covid-19?
Nisarga’s clinical trial was based on its patent-pending neem leaf extract, well researched for six years in pre-clinical studies with a reputed research institute in the US and toxicity studies completed as per the USFDA norms. Neem has been reported to exert anti-inflammatory, antibacterial/antiviral and antioxidant effects in our research as well as previously conducted anti-docking studies making it a potential p
May 10, 2021
×
Many companies have registered an uptick in sales, revenue and are tapping the digital space also
Riding on soaring sales of flagship products with the second wave of Covid-19, Health & Wellness firms are expecting a 35-50 per cent revenue growth in FY 2022.
Maheshwari Pharmaceuticals India Ltd (MPIL), a 25-year-old ayurvedic herbal pharma company based in Ghaziabad, Uttar Pradesh, sold five million units of its flagship product Amastha Awaleha (AA) in FY21 up from 3.5 million units the previous fiscal, contributing to 20 per cent of the company’s revenue of ₹36.5 crore.
The product, available in three variants and priced at ₹220-385 is described by the company as a ‘lung tonic’ for chronic bronchitis, bronchial asthma and COPD (chronic obstructive pulmonary disease) which is prescribed by doctors.